August 4, 2025

Table 1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy

View Full Paper

Ask AI

Bookmark

Modeling pediatric cancers in zebrafish provides valuable insights for developing precision therapies.
The study details molecular targets and clinical responses to therapy across various patient cohorts.
Patient-derived xenograft (PDX) models enhance understanding of tumor behavior and treatment response.
This research advances therapeutic strategies for high-risk pediatric cancers by improving model systems.

Implication

Analysis of clinical responses and molecular targets in high-risk pediatric cancers using zebrafish models, indicating potential for precision therapy.

Abstract

Patient cohort details, including molecular targets, clinical response to therapy, and mouse PDX development

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Azzam et al. (2025) studied this question.

synapsesocial.com/papers/689a0f8de6551bb0af8d0dea https://doi.org/10.1158/2767-9764.29644678

View Full Paper

Ask AI

Bookmark

Implication

Analysis of clinical responses and molecular targets in high-risk pediatric cancers using zebrafish models, indicating potential for precision therapy.

Abstract

Patient cohort details, including molecular targets, clinical response to therapy, and mouse PDX development

Table 1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Table 1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading